General Information of Drug Transporter (DT)
DT ID DTD0127 Transporter Info
Gene Name SLC19A2
Transporter Name Thiamine transporter 1
Gene ID
10560
UniProt ID
O60779
Post-Translational Modification of This DT
Overview of SLC19A2 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-N-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation

  Methionine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC19A2 [1]

Role of PTM

Potential impacts

Modified Residue

Methionine

Modified Location

1

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC19A2 Methionine 1 has the potential to affect its expression or activity.

N-glycosylation

  Asparagine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC19A2 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

63

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC19A2 Asparagine 63 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC19A2 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

314

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC19A2 Asparagine 314 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        10 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC19A2 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

8

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Serine 8 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC19A2 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

222

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Serine 222 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC19A2 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

244

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Serine 244 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC19A2 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

291

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Serine 291 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC19A2 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

292

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Serine 292 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC19A2 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

416

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Serine 416 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC19A2 [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

490

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Serine 490 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC19A2 [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

491

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Serine 491 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC19A2 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

492

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Serine 492 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC19A2 [6] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

497

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Serine 497 has the potential to affect its expression or activity.

  Threonine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC19A2 [5] , [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

223

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Threonine 223 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC19A2 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

241

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Threonine 241 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC19A2 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

405

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Threonine 405 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC19A2 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

408

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Threonine 408 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC19A2 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

495

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Threonine 495 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC19A2 [9] , [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

496

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Threonine 496 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC19A2 [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

290

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Tyrosine 290 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC19A2 [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

400

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A2 Tyrosine 400 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC19A2 [13]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

256

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC19A2 Lysine 256 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC19A2 [13]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

484

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC19A2 Lysine 484 has the potential to affect its expression or activity.
References
1 N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54.
2 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S19A2_HUMAN)
3 Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res. 2013 Jan 4;12(1):260-71.
4 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
5 Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
6 Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
7 Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 2014 Sep 11;8(5):1583-94.
8 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
9 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
10 Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal. 2011 Jun 28;4(179):rs5.
11 Identification of Candidate Cyclin-dependent kinase 1 (Cdk1) Substrates in Mitosis by Quantitative Phosphoproteomics. Mol Cell Proteomics. 2016 Jul;15(7):2448-61.
12 A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
13 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.